BioNTech Beefs Up AI/ML Investment With InstaDeep Buy
Executive Summary
The company is spending up to £562m to acquire artificial intelligence/machine learning provider InstaDeep, which it has partnered with since 2020, as competitor Moderna has made digital technology a cornerstone of its strategy.
You may also be interested in...
Biotech Industry Advised To Prepare For Incoming EU AI Regulation
The artificial intelligence revolution has arrived, but are drug and device companies ready to meet the expectations of regulators? Lawyer Vincenzo Salvatore outlines the EU regulatory and policy developments that are relevant to the use of AI in the medical product lifecycle.
Pharma Industry Advised To Prepare For Incoming EU AI Regulation
The artificial intelligence revolution has arrived, but are pharmaceutical companies ready to meet the expectations of regulators? Lawyer Vincenzo Salvatore outlines the EU regulatory and policy developments that are relevant to the use of AI in the medicinal product lifecycle.
Verge Builds Out Big Pharma AI Partnerships With AstraZeneca Deal
Deal Snapshot: Two years into a three-year partnership with Lilly, Verge announced another deal, with AstraZeneca’s Alexion, just months after acquiring bragging rights with early clinical data for an AI-discovered product candidate.